Date Filed | Type | Description |
08/17/2023 |
4
| Blackman Samuel C. (Head of Research and Developme) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 668 shares
@ $13.86, valued at
$9.3k
Exercised 1,187 restricted stock units
@ $0 Exercised 1,437 restricted stock units
@ $0 |
|
06/07/2023 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 1,229 shares
@ $16, valued at
$19.7k
|
|
06/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/17/2023 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 692 shares
@ $13.1223, valued at
$9.1k
Exercised 1,187 restricted stock units
@ $0 Exercised 1,437 restricted stock units
@ $0 |
|
05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/14/2023 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 10,000 shares
@ $18.0484, valued at
$180.5k
|
|
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/19/2023 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Granted 72,000 options to buy
@ $20.87, valued at
$1.5M
Granted 23,000 restricted stock units
@ $0 |
|
01/11/2023 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 7,500 shares
@ $22.751, valued at
$170.6k
Sold 2,500 shares
@ $23.2045, valued at
$58k
|
|
12/05/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 9,100 shares
@ $21.3835, valued at
$194.6k
Sold 900 shares
@ $22.1556, valued at
$19.9k
|
|
11/17/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 377 shares
@ $21.4598, valued at
$8.1k
Exercised 1,187 restricted stock units
@ $0 |
|
11/03/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 10,000 shares
@ $20.005, valued at
$200.1k
|
|
10/05/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 10,000 shares
@ $19.9852, valued at
$199.9k
|
|
09/06/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 8,411 shares
@ $23.1415, valued at
$194.6k
Sold 1,589 shares
@ $23.7938, valued at
$37.8k
|
|
08/17/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 941 shares
@ $24.31, valued at
$22.9k
Exercised 3,561 restricted stock units
@ $0 |
|
08/03/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 10,000 shares
@ $16.881, valued at
$168.8k
|
|
07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/20/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Granted 135,000 options to buy
@ $14.26, valued at
$1.9M
Granted 19,000 restricted stock units
@ $0 |
|
01/05/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Sold 6,672 shares
@ $16.9475, valued at
$113.1k
Sold 3,328 shares
@ $17.4111, valued at
$57.9k
|
|
12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |